CARDIFF ONCOLOGY
CRDF Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-03-11
2025-03-13
ERLANDER MARK
Chief Executive Officer
A - Grant
Stock Options
758K
$0.00
1
$200.91M
2025-03-11
2025-03-13
KABBINAVAR FAIROOZ
Chief Medical Officer
A - Grant
Stock Options
150K
$0.00
1
$200.91M
2024-12-18
2024-12-18
LEVINE JAMES
Chief Financial Officer
P - Purchase
Common Stock
2,400
$5.00
12,000
1
$200.91M
2024-12-17
2024-12-18
LEVINE JAMES
Chief Financial Officer
P - Purchase
Common Stock
2,752
$5.00
13,760
1
$200.91M
2024-12-16
2024-12-18
LEVINE JAMES
Chief Financial Officer
P - Purchase
Common Stock
2,564
$4.00
10,256
1
$200.91M
2024-03-07
2024-03-07
ERLANDER MARK
Chief Executive Officer
A - Grant
Stock Options
510K
$0.00
1
$200.91M
2024-03-07
2024-03-07
KABBINAVAR FAIROOZ
Chief Medical Officer
A - Grant
Stock Options
205K
$0.00
1
$200.91M
2023-03-15
2023-03-16
ERLANDER MARK
Chief Executive Officer
A - Grant
Stock Options
482K
$0.00
1
$200.91M
2022-11-25
2022-11-29
ERLANDER MARK
Chief Executive Officer
P - Purchase
Common Stock
10,000
$1.00
10,000
1
$200.91M
2022-09-16
2022-09-19
LEVINE JAMES
Chief Financial Officer
P - Purchase
Common Stock
30,000
$2.00
60,000
1
$200.91M
2022-03-09
2022-03-10
ERLANDER MARK
Chief Executive Officer
A - Grant
Stock Options
370K
$0.00
1
$200.91M
2022-03-09
2022-03-10
RUFFNER KATHERINE
Chief Medical Officer
A - Grant
Stock Options
170K
$0.00
1
$200.91M
2021-09-10
2021-09-13
LEVINE JAMES
Chief Financial Officer
P - Purchase
Common Stock
30,000
$6.00
180K
5
$200.91M
2021-07-12
2021-07-14
RUFFNER KATHERINE
Chief Medical Officer
A - Grant
Stock Options
200K
$0.00
1
$200.91M
2021-06-10
2021-06-14
ERLANDER MARK
Chief Executive Officer
A - Grant
Stock Options
435K
$0.00
1
$200.91M
2021-03-23
2021-03-23
ERLANDER MARK
Chief Executive Officer
P - Purchase
Common Stock
965
$10.00
9,650
1
$200.91M
2021-03-23
2021-03-23
KELEMEN VICKI
Exec. VP and COO
P - Purchase
Common Stock
960
$10.00
9,600
1
$200.91M
2021-01-02
2021-01-05
ERLANDER MARK
Chief Executive Officer
M - Exercise
Restricted Stock Units
-260
$0.00
1
$200.91M
2021-01-02
2021-01-05
ERLANDER MARK
Chief Executive Officer
M - Exercise
Common Stock
260
$0.00
1
$200.91M
2021-01-02
2021-01-05
KELEMEN VICKI
Exec. VP and COO
M - Exercise
Restricted Stock Units
-70
$0.00
1
$200.91M
2020-11-23
2020-11-25
KELEMEN VICKI
Exec. VP and COO
S - Sale
Common Stock
-35,321
$19.00
-671K
1
$200.91M
2020-11-23
2020-11-25
KELEMEN VICKI
Exec. VP and COO
M - Exercise
Stock Options
-35,321
$2.00
-70,642
1
$200.91M
2020-11-23
2020-11-25
KELEMEN VICKI
Exec. VP and COO
M - Exercise
Common Stock
35,321
$2.00
70,642
1
$200.91M
2020-06-17
2020-06-19
ERLANDER MARK
Chief Executive Officer
A - Grant
Stock Options
221K
$0.00
1
$200.91M
2020-05-14
2020-05-18
ERLANDER MARK
Chief Executive Officer
P - Purchase
Common Stock
6,993
$1.00
6,993
1
$200.91M